A New Therapy Offers Hope for HER2-Positive Pancreatic Cancer
An Innovative Hope for Pancreatic Cancer: A Case Study of PRaG 3.0 Therapy Pancreatic cancer is one of the deadliest forms of cancer, and when it spreads, it becomes even…
case
PRaG3.0: A Promising Treatment Strategy for Chemotherapy-Resistant Gastric Cancer
Introduction: A New Hope for Metastatic Gastric Cancer Gastric cancer (GC) is one of the most common and deadly cancers globally, especially in countries like China, where it accounts for…
A New Hope for Advanced Thyroid Cancer: The Power of Immunotherapy, Radiotherapy, and GM-CSF
Introduction to Thyroid Hürthle Cell Carcinoma and Its Challenges Thyroid cancer is the most common type of endocrine cancer, and among its subtypes, Hürthle cell carcinoma (HCC) is rare but…
Unveiling Abscopal Effects: A New Combination Therapy for Refractory Metastatic Breast Cancer
Metastatic triple-negative breast cancer (mTNBC) presents a formidable challenge due to its aggressive nature and poor prognosis. Despite numerous therapeutic approaches, such as surgery, chemotherapy, and radiotherapy, many patients with…
PRaG Therapy: A Promising Triple Approach for Advanced Malignant PEComa Treatment
Cancer treatment is a field where no two journeys are the same. The case of advanced malignant perivascular epithelioid cell neoplasm (PEComa), as described in this report, brings to light…
Reflections on a Treatment Journey: PRaG Therapy for Metastatic Colon Cancer
Introduction: The Ongoing Struggle Against Metastatic Colon Cancer As I read through the case of a metastatic colon cancer patient, it hit me how relentless and unforgiving this disease can…
A Novel Approach to Platinum-Resistant Ovarian Cancer: Interstitial Implantation Radiotherapy with Immunotherapy and GM-CSF
Introduction: The Challenge of Platinum-Resistant Ovarian CancerOvarian cancer, particularly in its platinum-resistant form, remains one of the most challenging gynecologic cancers to treat. Typically diagnosed at advanced stages, ovarian cancer’s…
PRaG therapy: A Game-Changing Approach for Refractory Metastatic ESCC
Introduction: A New Hope for Refractory Metastatic ESCCEsophageal squamous cell carcinoma (ESCC) is a highly aggressive cancer with a poor prognosis, often diagnosed at an advanced stage. Traditional treatment options,…
Unlocking the Potential of PRaG Therapy for Refractory Gastric Cancer: A Promising Case Study
Introduction: A Breakthrough in Metastatic Gastric Cancer TreatmentGastric cancer, particularly when metastatic, often presents with a poor prognosis, especially when conventional therapies have failed. Patients who cannot tolerate chemotherapy due…
A New Hope: PRaG 2.0 Regimen in the Fight Against Resistant Renal Pelvis Carcinoma
Introduction: Overcoming Resistance in Cancer TreatmentCancer therapy has come a long way in recent years, with immunotherapies, such as PD-1 inhibitors, showing great promise. However, resistance to these treatments remains…